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abstract

PURPOSE Authorship gender disparities persist across academic disciplines, including oncology. However, little
is known about global variation in authorship gender distribution.
METHODS This retrospective cross-sectional study describes the distribution of author gender as determined from
the ﬁrst name across variables such as authorship position (ﬁrst, middle, and last), country region, and country
income level. The 608 articles with 5,302 authors included in this analysis were published in the Journal of Clinical
Oncology Global Oncology, from its inception in October 2015 through March 2020. Primary outcome measure
was author gender on the basis of ﬁrst name probabilities assessed by genderize.io. World Bank classiﬁcation was
used to categorize the country region and income level. Odds ratios were used to describe associations between
female last authorship and representation in other authorship positions.
RESULTS Although female authors were in the minority across all authorship positions, they were more underrepresented in the last author position with 190 (32.1%) female, compared with 252 (41.4%) female ﬁrst authors
and 1,564 (38.1%) female middle authors. Female authors were most under-represented among authors from
low-income countries, where they made up 21.6% of ﬁrst authors and 9.1% of last authors. Of all the regions, subSaharan Africa and South Asia had the lowest percentage of female authors. Compared with articles with male last
authors, those with female last authors had odds ratios (95% CI) of 2.2 (1.6 to 3.2) of having female ﬁrst authors
and 1.4 (0.9 to 2.1) of having 50% or more female middle authors.
CONCLUSION There are wide regional variations in author gender distribution in global oncology. Female authors
remain markedly under-represented, especially in lower-income countries, sub-Saharan Africa, and South Asia.
Future interventions should be tailored to mitigate these disparities.
JCO Global Oncol 8:e2100369. © 2022 by American Society of Clinical Oncology
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In recent years, there has been increasing recognition of
authorship inequity in academic medicine publications.
A 2018 study of 54 prestigious scientiﬁc journals listed by
the Nature Index, across multiple scientiﬁc disciplines,
observed that 29.8% of all authors in a selection of 293,
557 articles were female.1 In several medical specialty
publications, female authors consistently comprise a
minority of ﬁrst authors and an even smaller percentage
of last authors.2-4 Although female authorship representation has increased in recent decades, change has
been both slow and inconsistent across various scientiﬁc
disciplines. A 2017 cross-sectional analysis of articles in
ﬁve premier oncology journals demonstrated that female
authors still comprised a minority of both ﬁrst (36.6%)
and last authors (28.5%).5 Similar gender disparities in
academic oncology leadership have also been described
across multiple domains including on editorial boards
and in cancer center leadership roles.6 This imbalance in

gender representation risks the perpetuation of systemic
bias in research priorities.7
With worldwide expansion of oncology scholarship and
the emergence of global oncology as an academic ﬁeld,
we sought to investigate authorship gender representation in global oncology publications. Although there are
complex arrays of factors that are associated with female authorship under-representation, the relationship
between author gender and the respective country region
and economic level has not been previously described.
This study describes the variation in authorship gender
distribution in global oncology publications across global
regions and country economic levels.
METHODS
This study analyzes data collected from articles published in the Journal of Clinical Oncology Global Oncology (JCO GO), an open-access journal published by
ASCO. JCO GO was selected for this analysis because
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CONTEXT
Key Objective
Authorship gender equity is imperative to ensure that research conducted reﬂects diverse perspectives. Imbalance in gender
representation risks the perpetuation of systemic bias in research priorities. With the emergence of global oncology as an
academic ﬁeld, we sought to investigate authorship gender representation in global oncology publication and to explore
variations in gender representation across global regions and country economic levels.
Knowledge Generated
Although female authors were in the minority across all authorship positions, they were most under-represented in the last
author position. Female authors were most under-represented among authors from low-income countries, and countries in
sub-Saharan Africa and South Asia.
Relevance
There was a trend toward rising proportion of female authors in the ﬁrst and last authorship positions in the most recent years,
particularly among articles published in 2020. However, more studies are needed to better inform targeted mitigating
interventions to improve authorship gender equity in the ﬁeld.

of its overarching global perspective and its discounted
article charge policy, making it relatively more accessible to
researchers from lower-resourced settings.8
A PubMed search was conducted to identify articles published
from the journal’s inception from October 2015 through March
2020. Of the 645 articles identiﬁed, 608 matched the speciﬁed
article type inclusion criteria representing editorials, commentaries, case reports, special articles, original reports, or reviews.
Correspondences, replies, and other miscellaneous articles
(n = 37) were excluded. Data were collected for each article
using the Research Electronic Data Capture tool.9,10 Using dual
data entry, H.T. and P.H. independently extracted data from 65

(10%) randomly selected articles. The percent discrepancy for
dual data entry was 7.5%, under the predetermined threshold
of 10% to proceed with single data entry. Data collection and
analysis were performed from April 2020 to April 2021.
Author gender was categorized as male, female, or indeterminate on the basis of ﬁrst name probability assessed by
genderize.io, a validated and widely used instrument.11 Gender
categorization used a threshold probability of 0.8 on the basis of
previous studies.11,12 Author primary country afﬁliation was
categorized on the basis of World Bank (WB) designations for
the 2020 ﬁscal year.13 The country region was classiﬁed by
the standard seven WB regions, and country income level
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FIG 1. Gender distribution by author position.
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FIG 2. Author gender distribution by region: (A) ﬁrst authors, (B) last authors, and
(C) middle authors.
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FIG 3. Author gender distribution by the country income level: (A) ﬁrst authors, (B) last authors, and (C) middle authors. HICs, high-income countries;
LICs, low-income countries; LMICs, lower-middle–income countries; UMICs, upper-middle–income countries.

classiﬁed by WB per-capita thresholds as low-income countries
(LICs), lower-middle–income countries (LMICs), upper-middle–income countries (UMICs), or high-income countries (HICs).
Statistical Analysis
Descriptive statistics using percentages and proportions
were used to report gender distribution and variations on
the basis of the variables of interest. The odds ratio was
used to describe the association between female authorship representation in the ﬁrst and middle author positions
with last author gender. Analyses were completed in SAS
version 9.4 (SAS Institute, Cary, NC).
Reporting and Ethical Considerations
This study was designated as exempt by the Dana-Farber
Cancer Institute Institutional Review Board. The report
follows the Strengthening the Reporting of Observational
Studies in Epidemiology (STROBE) guidelines for crosssectional studies.14
RESULTS
Overall, 2,006 (37.8%) of 5,302 total authors were female.
Female authors accounted for 252 (41.4%) ﬁrst authors, 1,
564 (38.1%) middle authors, and 190 (32.1%) last authors

(Fig 1). Gender distributions by region and country economic
level are shown in Figures 2 and 3, respectively. Among the
ﬁrst authors, females accounted for a higher proportion than
males in Europe and Central Asia (52.8% v 44.4%), and
North America (47.3% v 40.3%), whereas they were notably
under-represented in North Africa and the Middle East
(29.2% v 47.9%), South Asia (31.6% v 60.8%), and subSaharan Africa (30.8% v 64.1%). Similarly, female ﬁrst authors accounted for a higher proportion than males in HICs
(47.2% v 40.6%) and UMICs (47.6% v 41.3%), but the
converse was seen in LMICs (26.8% v 64.6%) and LICs
(21.6% v 70.3%). Among the last authors, females were
consistently under-represented across all regions and all
country economic strata. The lowest proportions of female last
authors were in South Asia (14.5%) and sub-Saharan Africa
(18.8%) and among the LIC (9.1%) and LMIC strata (18.9%).
Similar trends were observed among middle authors, where
females were under-represented across all economic strata
and most regions.
The distribution of authors by publication year is shown in
Figure 4. There appears to be a trend toward higher proportion of female ﬁrst authors in the most recent years.
Although the proportion of female ﬁrst authors in 2015 and

4 © 2022 by American Society of Clinical Oncology
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FIG 4. Authorship gender distribution by year: (A) ﬁrst authors, (B) last authors, and (C) middle authors.

2016 was 15.8% and 37.8%, respectively, this proportion
was notably higher in 2020 at 51.3%. In the last author
position, female authors were a minority from 2015 through
2019 with a proportion ranging from 25.5% to 31.9%;
however, they made up higher proportion in 2020 compared
with male authors (53.8% female v 37.2% male). Overall, the
proportion of female middle authors remained relatively
stable from year to year, ranging from 35.0% to 41.2%.
Figure 5 shows variation in author gender distribution by
article type. In the ﬁrst author position, female ﬁrst authors
were in the minority for original reports (39.0% female v
48.3% male). However, female ﬁrst authors made up a
higher proportion of authors for special articles (55.0%
female v 35.0%) and review articles (60.5% female v
32.6% male). In the middle and last author positions, female authors were more consistently in the minority across
all article types, except for editorials. Of note, there were

only 16 editorials, of which 11 had more than one author
and only three had middle authors.
We explored the association between having a female last
author and overall author composition; after excluding those
with indeterminate gender classiﬁcation, we found that
compared with articles with male last authors, those with
female last authors had odds ratios (95% CI) of 2.2 (1.6 to
3.2) of having female ﬁrst authors and 1.4 (0.9 to 2.1) of
having 50% or more female middle authors. On average,
articles with female last authors had a higher percentage of
female middle authors compared to those with male last
authors, 42.8% versus 36.7% (Fig 6). Of note, indeterminate
gender classiﬁcation accounted for 560 (10.6%) of the total
authors, with similar proportions in all the author positions
(Fig 1). However, the distribution of indeterminate authors
varied by region, with East Asia and Paciﬁc demonstrating
almost 25% indeterminate probability.

JCO Global Oncology
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FIG 5. Authorship gender distribution by article type: (A) ﬁrst authors, (B) last authors, and (C) middle authors.

DISCUSSION
In this study of gender distribution in global oncology
publications, in aggregate, female authors were in the minority across all authorship positions, especially in the last
author position. However, there was a substantial variation
across regions and economic strata. Although female ﬁrst
authors outnumbered male ﬁrst authors in UMICs and HICs,
particularly from Europe and North America, female authors
remained markedly under-represented especially in the
middle and last author positions across LICs and LMICs.
Female ﬁrst authors were in the minority for original report
articles but made up a higher proportion of ﬁrst authors on
review and special articles. In addition, there appears to be a
trend toward increasing female authorship representation in
the more recent years, with articles in 2020 having the
highest proportion of female ﬁrst and last authors. We also
showed that having female last authors, who typically represent the research team leaders, was associated with a
higher proportion of female ﬁrst authors and middle authors.

To our knowledge, our report is the ﬁrst to describe the variation in authorship gender distribution in any medical specialty
by region and economic status. Gains in authorship gender
parity are occurring in oncology publications and our ﬁndings
indicate that these gains are largely occurring in UMICs and
HICs in North America and Europe, whereas signiﬁcant disparities persist in many regions.5 Authorship representation
offers a window into the historical systemic issue of female
under-representation in academic oncology. For example,
although the proportion of US female graduates of hematology
and oncology fellowship programs now approaches 50%,
female department leaders and full professors remain under
30%.15,16 Achieving authorship gender parity will require
concerted efforts such as active recruitment of trainees, fostering engagement in research, facilitating mentorship, and
supporting advancement up the academic ladder. The trend
toward higher female authorship representation in 2020, the
most recent year in the study, is encouraging and may be an
early indication of the impact of ongoing efforts.

6 © 2022 by American Society of Clinical Oncology
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This study also highlights the important role of female leadership in fostering greater gender diversity across academic
teams.3 This positive effect, which has been described in other
ﬁelds, may be related to effective mentorship and sponsorship
for women in earlier career stages.17 Although earlier studies
have described that women in academic medicine noted less
access to career mentorship, the development of formal
mentorship programs has been shown to be associated with
increased career satisfaction.17-19 The higher proportion of
female ﬁrst authors in HICs and UMICs provides hope that
progress toward equitable representation in academic research is possible.
There are emerging programs in LICs and LMICs focused
on academic research mentorship of women; one such
example is a recent initiative by the Pan-African Women’s
Association of Surgeons that targets female surgeons
across Africa for mentorship in research methodology and
project management.20 Such initiatives hold the potential
to increase the pipeline of female researchers and the
scope of scholarly output by female authors from these
regions.
Further study is needed to better understand the various
barriers that women face in pursing academic medical
careers. These factors may include societal contextual
factors, such as perceptions of the role of women in
leadership and expectations of family responsibilities.
These studies will help inform the design and evaluation of
future tailored interventions to improve academic engagement and authorship participation of women in regions with the most profound under-representation. In
addition, systematic collection and reporting of selfreported gender identity by oncology journals will be
important to measure future progress and promote accountability toward gender parity.

This study has some limitations. There is potential for gender
misclassiﬁcation using ﬁrst name probabilities for ascertainment. To limit this bias, we used a stringent probability
threshold of 80%, which resulted in 10.5% of the authors
being classiﬁed as indeterminate. However, given variation in
naming practices and the use of gender-neutral names
around the globe, the proportion of indeterminate genders
was not evenly distributed across regions. The higher proportion of indeterminate gender in East Asia and Paciﬁc, and
South Asia may limit the generalizability of the ﬁndings. It is
also important to acknowledge the ﬂuidity of gender identiﬁcation, which is not fully reﬂected using male or female
binary.
Another limitation is that the study involves publications
from one journal, in which North American and European
authors are over-represented. Hence, the reported ﬁndings
may not represent authorship distribution in other oncology
journals. Finally, the study was conceived before the
COVID-19 pandemic and only includes articles published
up to March 2020. Therefore, the results do not reﬂect the
potential differential impact of the COVID-19 pandemic on
academic productivity. Future studies should explore
changes in productivity and academic engagement of
clinicians and researchers in the COVID-19 era and beyond
and explore the impact on authorship equity.
In conclusion, our analysis shows that authorship gender
inequities persist in global oncology publications. Female
authors from lower-income countries and regions in subSaharan Africa and South Asia remain markedly underrepresented. Moreover, the higher proportions of female
ﬁrst authors in HICs and UMICs are promising signs of
progress toward more equitable representation. Future
investigation and interventions should be tailored especially
to regions with the greatest disparities.

JCO Global Oncology

Downloaded from ascopubs.org by 197.138.76.2 on February 14, 2022 from 197.138.076.002
Copyright © 2022 American Society of Clinical Oncology. See https://ascopubs.org/go/authors/open-access for reuse terms.

7

Hornstein et al

AFFILIATIONS
1

Kaiser Permanente Bernard J. Tyson School of Medicine, Pasadena, CA
2
Partners In Health, Boston, MA
3
Breast Surgical Oncology, Aga Khan University, Nairobi, Kenya
4
Department of Radiation Medicine, University of Nigeria Teaching
Hospital, Enugu, Nigeria
5
Rwanda Military Hospital, Kigali, Rwanda
6
Center for Global Cancer Medicine, Dana-Farber Cancer Institute, Boston, MA

CORRESPONDING AUTHOR
Temidayo Fadelu, MD, MPH, Dana-Farber Cancer Institute, 450
Brookline Ave, MA-1B-17, Boston, MA 02215; e-mail: temidayo_
fadelu@dfci.harvard.edu.

EQUAL CONTRIBUTION
R.H. and H.T. contributed equally to this work.

PRIOR PRESENTATION
Presented as a poster at the 2021 ASCO Annual Meeting, June 4-8,
2021, virtual.

AUTHOR CONTRIBUTIONS
Conception and design: Paula Hornstein, Hubert Tuyishime, Miriam
Mutebi, Nwamaka Lasebikan, Temidayo Fadelu
Administrative support: Hubert Tuyishime, Temidayo Fadelu

Collection and assembly of data: Paula Hornstein, Hubert Tuyishime,
Temidayo Fadelu
Data analysis and interpretation: All authors
Manuscript writing: All authors
Final approval of manuscript: All authors
Accountable for all aspects of the work: All authors

AUTHORS’ DISCLOSURES OF POTENTIAL CONFLICTS OF
INTEREST
The following represents disclosure information provided by authors of this
manuscript. All relationships are considered compensated unless otherwise
noted. Relationships are self-held unless noted. I = Immediate Family Member,
Inst = My Institution. Relationships may not relate to the subject matter of this
manuscript. For more information about ASCO’s conﬂict of interest policy,
please refer to www.asco.org/rwc or ascopubs.org/go/authors/author-center.
Open Payments is a public database containing information reported
by companies about payments made to US-licensed physicians
(Open Payments).
Miriam Mutebi
This author is a member of the JCO Global Oncology Editorial Board.
Journal policy recused the author from having any role in the peer review
of this manuscript.
Temidayo Fadelu
Research Funding: Celgene (Inst), Cepheid (Inst)
No other potential conﬂicts of interest were reported.

REFERENCES
1.

Bendels MHK, Müller R, Brueggmann D, et al: Gender disparities in high-quality research revealed by Nature Index journals. PLoS One 13:e0189136, 2018

2.

Jagsi R, Guancial EA, Worobey CC, et al: The “gender gap” in authorship of academic medical literature—A 35-year perspective. N Engl J Med 355:281-287,
2006

3.

Hart KL, Perlis RH: Trends in proportion of women as authors of medical journal articles, 2008-2018. JAMA Intern Med 179:1285, 2019

4.

Filardo G, da Graca B, Sass DM, et al: Trends and comparison of female ﬁrst authorship in high impact medical journals: Observational study (1994-2014). BMJ
352:i847, 2016

5.

Dalal NH, Chino F, Williamson H, et al: Mind the gap: Gendered publication trends in oncology. Cancer 126:2859-2865, 2020

6.

Alwazzan L, Al-Angari SS: Women’s leadership in academic medicine: A systematic review of extent, condition and interventions. BMJ Open 10:e032232, 2020

7.

Penny M, Jeffries R, Grant J, et al: Women and academic medicine: A review of the evidence on female representation. J R Soc Med 107:259-263, 2014

8.

About | JCO Global Oncology. https://ascopubs.org/go/about/about-go

9.

Harris PA, Taylor R, Minor BL, et al: The REDCap consortium: Building an international community of software platform partners. J Biomed Inform 95:103208,
2019

10. Harris PA, Taylor R, Thielke R, et al: Research electronic data capture (REDCap)—A metadata-driven methodology and workﬂow process for providing
translational research informatics support. J Biomed Inform 42:377-381, 2009
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